Dr. Stephenson graduated from the Michigan State University College of Human Medicine in 1993. She works in Columbia, SC and 1 other location and specializes in Pediatrics. Dr. Stephenson is affiliated with Palmetto Health Baptist and Palmetto Health Richland Hospital.
License Records
Kathryn Mary Stephenson
License #:
109671-0701 - Expired
Category:
Dental
Issued Date:
Jan 1, 1910
Expiration Date:
May 31, 2002
Type:
Dental Hygienist
Name / Title
Company / Classification
Phones & Addresses
Kathryn Stephenson Principal
Mint Marketing LLC Management Consulting Services
20616 NW Sauvie Is Rd, Portland, OR 97231 5036213530
Youtube
COVID-19 Vaccines - State of the Art - Kathr...
Lecture: COVID-19 Vaccines - State of the Art Speaker: Kathryn Stephen...
Duration:
31m 50s
COVID-19 Vaccine Boosters - Where Are We Now?...
Lecture: COVID-19 Vaccine Boosters - Where Are We Now? Speaker: Kathry...
Duration:
21m 58s
Kathryn Stephenson has an amazing voice!!
My beautiful cousin and her beautiful voice!!
Duration:
42s
Vaccines and Immunity to SARS-CoV-2 | Kathryn...
Lecture: Vaccines and Immunity to SARS-CoV-2 Speaker: Kathryn Stephens...
Duration:
14m 28s
COVID-19 Vaccines, HIV and Aging | Kathryn St...
Title: COVID-19 Vaccines, HIV and Aging Speaker: Kathryn Stephenson, M...
Duration:
11m 33s
SARS-COV-2 Vaccines: A Critical Review - Kath...
Title: SARS-COV-2 Vaccines: A Critical Review Speaker: Kathryn Stephen...
about immune imprinting, scientists are learning more than ever about the process thanks to COVID, Dr. Kathryn Stephenson, assistant professor of medicine and infectious disease expert at Beth Israel Deaconess Medical Center in Massachusetts, said Thursday at a Harvard-affiliated COVID press conference.
Date: Nov 18, 2022
Category: More news
Source: Google
COVID rebound is surprisingly common — even without Paxlovid
The study, led by infectious-disease physician and vaccine scientist Kathryn Stephenson at Beth Israel Deaconess Medical Center in Boston, closely followed 11 people who took Paxlovid for COVID-19 and 25 who did not. More than one-quarter of the Paxlovid recipients rebounded, based on levels of SARS
Date: Aug 11, 2022
Category: Health
Source: Google
The Color of COVID: Will Vaccine Trials Reflect America's Diversity?
Still, the pressure to produce an effective vaccine quickly during a pandemic could sideline efforts to ensure diversity, said Dr. Kathryn Stephenson, director of the clinical trials unit in the Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center in Boston.